Clinical Trials Browser

Phase 2 × Biliary Tract Neoplasms × Ipilimumab × Clear all

NCT02866383 2023-09-22

CheckPAC

Phase 2 Completed

Gastrointestinal

Biliary Tract Neoplasms, Pancreatic Neoplasms

NCT03101566 2022-10-28

Study of Nivolumab in Combination With Gemcitabine/Cisplatin or Ipilimumab for Patients With Advanced Unresectable Biliary Tract Cancer

Phase 2 Completed

75 enrolled 14 charts

Gastrointestinal

Biliary Tract Neoplasms